Phase 1 Technology Commercialization Grant: Rapid identification of in cellulo active cyclic-peptides inhibiting ‘undruggable’ targets requiring sub-type binding specificity
Phase 1 Technology Commercialization Grant: Rapid identification of in cellulo active cyclic-peptides inhibiting ‘undruggable’ targets requiring sub-type binding specificity